Needle-size device created to track tumors, radiation dose

Engineers at Purdue University are creating a wireless device designed to be injected into tumors to tell doctors the precise dose of radiation received and locate the exact position of tumors during treatment.

The information would help to more effectively kill tumors, said Babak Ziaie, an associate professor in the School of Electrical and Computer Engineering and a researcher at Purdue's Birck Nanotechnology Center.

Ziaie is leading a team that has tested a prototype "wireless implantable passive micro-dosimeter" and said the device could be in clinical trials in 2010.

"Because organs and tumors shift inside the body during treatment, a new technology is needed to tell doctors the exact dosage of radiation received by a tumor," Ziaie said.

The prototype is enclosed in a glass capillary small enough to inject into a tumor with a syringe, said Ziaie, who has a dual appointment in Purdue's Weldon School of Biomedical Engineering.

Research findings are detailed in a paper appearing in the June issue of IEEE Transactions On Biomedical Engineering. The paper was written by doctoral student Chulwoo Son and Ziaie.

Whereas conventional imaging systems can provide a three-dimensional fix on a tumor's shifting position during therapy, these methods are difficult to use during radiation therapy, are costly and sometimes require X-rays, which can damage tissue when used repeatedly, Ziaie said.

The new device uses radio frequency identification, or RFID, technology, which does not emit damaging X-rays.

The device, which has no batteries and will be activated with electrical coils placed next to the patient, contains a miniature version of dosimeters worn by workers in occupations involving radioactivity. The tiny dosimeter could provide up-to-date information about the cumulative dose a tumor is receiving over time.

"It's a radiation dosimeter and a tracking device in the same capsule and will be hermetically sealed so that it will not have to be removed from the body," Ziaie said.

The same researchers in 2006 reported findings on the first such miniature device. However, the earlier prototype lacked adequate sensitivity, was too large and not suitable for easy implantation, Ziaie said.

New findings detail the development of a miniaturized and more sensitive dosimeter that can be implanted using a hypodermic needle. Researchers tested the prototype with radioactive cobalt.

The researchers have been funded by the National Science Foundation and recently received a two-year grant from the National Institutes of Health to continue the work. Over that time, the research team will work to simplify the fabrication process so that the devices could be manufactured inexpensively.

A key advantage of the technology is that it does not require intricate circuitry, which could make the device easier and less expensive to manufacture than more complex designs. The system consists of simple electronic devices called capacitors and coils.

The device has a diameter of about 2.5 millimeters, or thousandths of a meter, and is about 2 centimeters long, making it small enough to fit inside a large-diameter needle for injection with a syringe. The current size is small enough to be used in tumors, but researchers will work to shrink the device to about half a millimeter in diameter and half its current length, roughly the size of a rice grain, said Ziaie, who is working with Byunghoo Jung, a Purdue assistant professor of electrical and computer engineering.

Source: Purdue University

Related stories:

Wireless cancer treatment device developed
Purdue University scientists are building a tiny wireless device that could be implanted in tumors to register the precise dose of radiation received.
Circulating tumor cells can reveal genetic signature of dangerous lung cancers
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
Fireflies' glow helps researchers track cancer drug's effectiveness
The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.
New technology puts biomedical imaging in palm of hands
Researchers at Georgia Tech have developed a narrowband filter mosaic that will expand the uses and functionality of multispectral imaging—a technology that enables subsurface characterization. The new, single-exposure imaging tool could significantly improve point-of-care medical and forensic imaging by empowering front line clinicians with no specialized training to detect and assess, in real-time, the severity of bruises and erythema, regardless of patient skin pigmentation or available lighting.
Engineers demonstrate first room-temperature semiconductor source of coherent Terahertz radiation
Engineers and applied physicists from Harvard University have demonstrated the first room-temperature electrically-pumped semiconductor source of coherent Terahertz (THz) radiation, also known as T-rays. The breakthrough in laser technology, based upon commercially available nanotechnology, has the potential to become a standard Terahertz source to support applications ranging from security screening to chemical sensing.
Prism glasses expand the view for patients with hemianopia
Innovative prism glasses can significantly improve the vision and the daily lives of patients with hemianopia, a condition that blinds half the visual field in both eyes. The peripheral prism glasses, which were invented by Dr. Eli Peli, a Senior Scientist at Schepens Eye Research Institute, were evaluated in the first community-based multi-center trial of such a device, which is published in the May issue of the Archives of Ophthalmology. The study was coordinated by Dr. Alex Bowers, a Senior Scientific Associate at the Institute.
Researchers develop method for transmitting medical images via cell phones
A process to transmit medical images via cellular phones that has been developed by a Hebrew University of Jerusalem researcher has the potential to provide sophisticated radiological diagnoses and treatment to the majority of the world’s population lacking access to such technology. This would include millions in developing nations as well as those in rural areas of developed countries who live considerable distances from modern medical centers.
Prototype Terahertz Imager Promises Biochem Advances
Researchers at the National Institute of Standards and Technology have demonstrated a new imaging system that detects naturally occurring terahertz radiation with unprecedented sensitivity and resolution. The technology may become a new tool chemical and biochemical analyses ranging from early tumor detection to rapid and precise identification of chemical hazards for homeland security instruments.

News discussion:

Technology news